University of Miami-Miller School of Medicine

Latest from University of Miami-Miller School of Medicine


Neflamapimod Displays Robust Efficacy in Pure Lewy Body Dementia Pathology

November 19, 2021

The magnitude of neflamapimod’s effect on several efficacy measures proved to be consistent with the mechanism of action and prior preclinical data, with p-tau181 data suggesting a stronger effect on nonmixed Lewy body pathology.

COVID-19’s Potential Effect on Dementia Risk: James E. Galvin, MD, MPH

September 01, 2021

The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed the current understanding of COVID-19 and its associations with cognitive decline and Alzheimer disease.

Dementia Research in Multicultural Communities: James E. Galvin, MD, MPH

August 30, 2021

The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed projects dedicated towards improving dementia recognition and care within multicultural communities.